Synthesis and antileukemic activity of bis[[(carbamoyl)oxy]methyl]- substituted pyrrolo[2,1-a]isoquinolines, pyrrolo[1,2-a]quinolines, pyrrolo[2,1-a]isobenzazepines, and pyrrolo[1,2-a]benzazepines

J Med Chem. 1988 Nov;31(11):2097-102. doi: 10.1021/jm00119a008.

Abstract

A series of bis[[(carbamoyl)oxy]methyl]-substituted pyrrole-fused tricyclic heterocycles were synthesized by using 1,3-dipolar cycloaddition reactions with a trifluoromethanesulfonate salt of an appropriate Resissert compound or with a mesoionic oxazolone intermediate. All of the bis(carbamates) were active in vivo against P388 lymphocytic leukemia with 5,6-dihydro-8-methoxy-1,2- bis(hydroxymethyl)pyrrolo[2,1-a]isoquinoline bis[N-(2-propyl)carbamate] (3c) showing the highest level of activity.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / therapeutic use
  • Benzazepines / chemical synthesis
  • Benzazepines / therapeutic use
  • Carbamates / chemical synthesis*
  • Carbamates / therapeutic use
  • Isoquinolines / chemical synthesis
  • Isoquinolines / therapeutic use
  • Leukemia P388 / drug therapy*
  • Leukemia, Experimental / drug therapy*
  • Mice
  • Pyrroles / chemical synthesis
  • Pyrroles / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzazepines
  • Carbamates
  • Isoquinolines
  • Pyrroles